SOPHARMA (SPH): Sales revenues for April 2019 - raport 12
Raport ESPI
UNI - EN REPORT No
12
/
2019
UNI - EN REPORT No12/2019
Sopharma AD (the “Company”) notifies that for April 2019 the Company recorded a decrease of sales revenues of 7% compared to the same month of 2018, incl. keeping the sales for the domestic market and a decrease of 11% of export sales.
In the first four months of 2019 the revenues from sales of production decreased by 3% compared to the same period of 2018, including 15% decrease in domestic sales and 5% increase of export sales.
